Literature DB >> 11557596

Effects of oxidant stress on inflammation and survival of iNOS knockout mice after marrow transplantation.

S Yang1, V A Porter, D N Cornfield, C Milla, A Panoskaltsis-Mortari, B R Blazar, I Y Haddad.   

Abstract

In a model of idiopathic pneumonia syndrome after bone marrow transplantation (BMT), injection of allogeneic T cells induces nitric oxide (.NO), and the addition of cyclophosphamide (Cy) generates superoxide (O.) and a tissue-damaging nitrating oxidant. We hypothesized that.NO and O. balance are major determinants of post-BMT survival and inflammation. Inducible nitric oxide synthase (iNOS) deletional mutant mice (-/-) given donor bone marrow and spleen T cells (BMS) exhibited improved survival compared with matched BMS controls. Bronchoalveolar lavage fluids obtained on day 7 post-BMT from iNOS(-/-) BMS mice contained less tumor necrosis factor-alpha and interferon-gamma, indicating that.NO stimulated the production of proinflammatory cytokines. However, despite suppressed inflammation and decreased nitrotyrosine staining, iNOS(-/-) mice given both donor T cells and Cy (BMS + Cy) died earlier than iNOS-sufficient BMS + Cy mice. Alveolar macrophages from iNOS(-/-) BMS + Cy mice did not produce.NO but persisted to generate strong oxidants as assessed by the oxidation of the intracellular fluorescent probe 2',7'-dichlorofluorescin. We concluded that.NO amplifies T cell-dependent inflammation and addition of Cy exacerbates.NO-dependent mortality. However, the lack of.NO during Cy-induced oxidant stress decreases survival of T cell-recipient mice, most likely by generation of.NO-independent toxic oxidants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557596     DOI: 10.1152/ajplung.2001.281.4.L922

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

Review 1.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

2.  Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

Authors:  M Hanief Sofi; Yongxia Wu; Steven D Schutt; Min Dai; Anusara Daenthanasanmak; Jessica Heinrichs Voss; Hung Nguyen; David Bastian; Supinya Iamsawat; Shanmugam Panneer Selvam; Chen Liu; Nilanjana Maulik; Besim Ogretmen; Junfei Jin; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2019-05-02       Impact factor: 14.808

3.  Markers of nitric oxide are associated with sepsis severity: an observational study.

Authors:  Martin Sebastian Winkler; Stefan Kluge; Maximilian Holzmann; Eileen Moritz; Linda Robbe; Antonia Bauer; Corinne Zahrte; Marion Priefler; Edzard Schwedhelm; Rainer H Böger; Alwin E Goetz; Axel Nierhaus; Christian Zoellner
Journal:  Crit Care       Date:  2017-07-15       Impact factor: 9.097

Review 4.  A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.

Authors:  Lama Elbahlawan; Ashok Srinivasan; R Ray Morrison
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-25       Impact factor: 5.742

5.  Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.

Authors:  Martin Sebastian Winkler; Axel Nierhaus; Gilbert Rösler; Susanne Lezius; Olaf Harlandt; Edzard Schwedhelm; Rainer H Böger; Stefan Kluge
Journal:  Crit Care       Date:  2018-09-19       Impact factor: 9.097

Review 6.  Nitric oxide in cellular adaptation and disease.

Authors:  Benjamin N Gantner; Katy M LaFond; Marcelo G Bonini
Journal:  Redox Biol       Date:  2020-04-25       Impact factor: 11.799

7.  Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD).

Authors:  Jung H Suh; Bindu Kanathezhath; Swapna Shenvi; Hua Guo; Alicia Zhou; Anureet Tiwana; Frans Kuypers; Bruce N Ames; Mark C Walters
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.